Lilly Eli & Co
An insider at 2 companies in coverage, as reported on Form 4. SEC CIK 59478. Latest Form 4 filed Nov 12, 2014.
Roles
As stated on the filings: the relationship to the company and any officer title.
| Company | Role | Transactions | First | Latest |
|---|---|---|---|---|
| Coherus Oncology, Inc.CHRS | Former 10% Owner | 5 | 2014-11-12 | 2014-11-12 |
| Dare Bioscience, Inc.DARE | 10% owner | 9 | 2014-04-15 | 2014-04-15 |
Transactions: 14
Every transaction reported, newest first, including grants, exercises and derivative securities. Purchases and sales (codes P and S) are open-market trades. The reported price is as stated on the form.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Company | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2014-11-12 | Coherus Oncology, Inc.Former 10% Owner | ConversionSeries C Preferred Stock | 543,101 | not reported | not reported | Form 4 |
| 2014-11-12 | Coherus Oncology, Inc.Former 10% Owner | ConversionSeries B Preferred Stock | 2,333,955 | not reported | not reported | Form 4 |
| 2014-11-12 | Coherus Oncology, Inc.Former 10% Owner | Purchase | 164,963 | $13.50 | $2.2m | Form 4 |
| 2014-11-12 | Coherus Oncology, Inc.Former 10% Owner | Conversion | 543,101 | not reported | not reported | Form 4 |
| 2014-11-12 | Coherus Oncology, Inc.Former 10% Owner | Conversion | 2,333,955 | not reported | not reported | Form 4 |
| 2014-04-15 | Dare Bioscience, Inc.10% owner | Conversion7% Convertible Promissory Notes | not reported | $0.00 | not reported | Form 4 |
| 2014-04-15 | Dare Bioscience, Inc.10% owner | Conversion7% Convertible Promissory Notes | not reported | $0.00 | not reported | Form 4 |
| 2014-04-15 | Dare Bioscience, Inc.10% owner | ConversionSeries D Convertible Preferred Stock | 4,340,831 | $0.00 | $0 | Form 4 |
| 2014-04-15 | Dare Bioscience, Inc.10% owner | ConversionSeries C Convertible Preferred Stock | 13,513,513 | $0.00 | $0 | Form 4 |
| 2014-04-15 | Dare Bioscience, Inc.10% owner | Purchase | 733,445 | $7.00 | $5.1m | Form 4 |
| 2014-04-15 | Dare Bioscience, Inc.10% owner | Conversion | 199,875 | not reported | not reported | Form 4 |
| 2014-04-15 | Dare Bioscience, Inc.10% owner | Conversion | 192,209 | not reported | not reported | Form 4 |
| 2014-04-15 | Dare Bioscience, Inc.10% owner | Conversion | 299,213 | not reported | not reported | Form 4 |
| 2014-04-15 | Dare Bioscience, Inc.10% owner | Conversion | 931,485 | not reported | not reported | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 30, 2026, 20:54 ET. Listed shows no prices and gives no investment advice.